Biogen, Genentech appeal Arzerra ruling for GSK; Ranbaxy launches copy of Pfizer's Caduet;

FiercePharma: FDA weighs Teva's request to bring Plan B contraceptive out from behind the pharmacists' counter. News | Follow @FiercePharma

> Roche's Genentech unit and Biogen Idec ($BIIB) are appealing a judgment in favor of GlaxoSmithKline ($GSK) in a patent fight over the blood cancer drug Arzerra. Report

> Ranbaxy Laboratories has launched its generic version of Pfizer's ($PFE) blood-pressure drug Caduet in the U.S. News

> GlaxoSmithKline ($GSK) has nabbed one necessary approval for its offshore wind-turbine site near Montrose in Scotland. Item

> Ex-NFL players are suing the league and its teams, saying they were given the blood-thinning painkiller Toradol before and during games, worsening injuries such as concussions. Story

> India's Elder Pharmaceuticals is poised to jump into the Japanese market, armed with regulatory approval for its API plant in Patalganga. Piece

> Cobb County, GA gave Osmotica Pharmaceutical a $564,539 tax break in exchange for creating 144 jobs at a former Solvay Pharmaceuticals site. More

> Asahi Kasei Pharma launched its subcutaneous injectable form of Teribone, an osteoporosis remedy, in Japan. Report 

Biotech News

@FierceBiotech: Biogen Idec signs up with Samsung on $300 million biosimilars venture. News | Follow @FierceBiotech

@JohnCFierce: Sustained release levodopa/carbidopa (xenoport) fails Ph2 Parkinson's study. Does anyone really understand this field? Report | Follow @JohnCFierce

@RyanMFierce: Sanofi's GLP-1 drug yields upbeat data in pivotal study in T2DM. GLP-1 class growing beyond Byetta/Bydureon, Victoza. Item | Follow @RyanMFierce

@FierceMedDev: Randox's new molecular diagnostic test permits quick selection of colorectal cancer patients for Anti-EGFR therapy. Release | Follow @FierceMedDev

> Merck blueprints Asian R&D HQ in Beijing in $1.5B research blitz. News

Biotech Research News

> Partial, lab-grown pituitary gland works in mice. News

> Gene may hold back skin, head, neck cancers. Story

> Researchers unmask protein as villain in pancreatic, brain cancer growth. Item

> Search is on for new anti-addiction drug targets. Article

> Adult stem cell pathway could yield better muscle disorder treatments. Report

Manufacturing News

> Pfizer presence unmistakable in 1940s Brooklyn. News

> MA anticipates bioprocess job increase. Item

> Theravance MRSA drug a victim of Ben Venue shutdown. Report

> Issue separates bio, small molecule CMOs. News

> Online vaccines available from suspect sources. Article

And Finally... Flu vaccination rates are up this year, especially among children. Report